Details
Stereochemistry | RACEMIC |
Molecular Formula | C11H17N2O2S.Na |
Molecular Weight | 264.32 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CCCC(C)C1(CC)C(=O)NC(=S)[N-]C1=O
InChI
InChIKey=AWLILQARPMWUHA-UHFFFAOYSA-M
InChI=1S/C11H18N2O2S.Na/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15;/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16);/q;+1/p-1
Sodium thiopental (also known as Sodium Pentothal, thiopental) was discovered in 1930s by investigators working for Abbott Laboratories. Thiopental sodium was used for the induction of general anesthesia and is used as an adjunct to provide hypnosis during balanced anesthesia with other anesthetic agents, including analgesics and muscle relaxants. Thiopental sodium was also used as an adjunct for control of convulsive disorders of various etiology, including those caused by local anesthetics. Finally, thiopental sodium had been used to reduce the intracranial pressure in patients with increased intracranial pressure, if controlled ventilation is provided. Nevertheless, these prescriptions of drug were discontinued. In addition, this drug was banned for use in US executions. Thiopental sodium acts through the CNS with particular activity in the mesencephalic reticular activating system. It was shown, that mechanism of action of sodium thiopental via GABAA receptor. Thiopental binds at a distinct binding site associated with a Cl- ionopore at the GABAA receptor, increasing the duration of time for which the Cl- ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2093872 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18619475 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | PENTOTHAL Approved UsePentothal (Thiopental Sodium for Injection) is indicated (1) as the sole anesthetic agent for brief (15 minute) procedures, (2) for induction of anesthesia prior to administration of other anesthetic agents, (3) to supplement regional anesthesia, (4) to provide hypnosis during balanced anesthesia with other agents for analgesia or muscle relaxation, (5) for the control of convulsive states during or following inhalation anesthesia, local anesthesia, or other causes, (6) in neurosurgical patients with increased intracranial pressure, if adequate ventilation is provided, and (7) for narcoanalysis and narcosynthesis in psychiatric disorders. |
Doses
Dose | Population | Adverse events |
---|---|---|
500 mg multiple, intravenous (starting) Dose: 500 mg Route: intravenous Route: multiple Dose: 500 mg Sources: |
unhealthy, 31 years (range: 19 -44 years) n = 13 Health Status: unhealthy Age Group: 31 years (range: 19 -44 years) Sex: M+F Population Size: 13 Sources: |
Other AEs: Hypothermia... |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Hypothermia | 1 patient | 500 mg multiple, intravenous (starting) Dose: 500 mg Route: intravenous Route: multiple Dose: 500 mg Sources: |
unhealthy, 31 years (range: 19 -44 years) n = 13 Health Status: unhealthy Age Group: 31 years (range: 19 -44 years) Sex: M+F Population Size: 13 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Metabolism of thiopental-S35 and thiopental-2-C14 by a rat liver mince and identification of pentobarbital as a major metabolite. | 1955 Jul |
|
Case reports: thiopentone anaphylaxis. | 1972 Aug |
|
Abdominal-muscle rigidity induced by morphine and nitrous oxide. | 1973 Apr |
|
Postischemic brain oxygenation with barbiturate therapy in rats. | 1979 Aug |
|
The safety of etomidate: a new intravenous anaesthetic induction agent. | 1983 Jun |
|
Domperidone--an acute dystonic reaction. | 1985 Feb |
|
Asystole associated with vecuronium. | 1986 Aug |
|
Comparison of the induction characteristics of thiopentone and propofol in children. | 1987 Nov |
|
Factors that influence cutaneous reactions following administration of thiopentone and atracurium. | 1988 Oct |
|
[Muscular rigidity caused by alfentanil: prevention]. | 1989 Jun |
|
[Hemodynamic effects of the induction of general anesthesia after low thoracic epidural anesthesia]. | 1991 |
|
Protective effect of thiopental against cerebral ischemia during circulatory arrest. | 1999 Aug |
|
The influence of the timing of administration of thiopentone sodium on nitric oxide-mediated neurotoxicity in vitro. | 2000 Mar 1 |
|
Effect of propofol at two injection rates or thiopentone on post-intubation apnoea in the dog. | 2001 Feb |
|
Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients. | 2001 Nov |
|
Interaction of intravenous anesthetics with recombinant human M1-M3 muscarinic receptors expressed in chinese hamster ovary cells. | 2002 Dec |
|
Life-threatening hyperkalaemia following therapeutic barbiturate coma. | 2002 Sep |
|
Effect of sodium succinate on gas exchange in rats with barbiturate-induced coma. | 2003 Apr |
|
Thiopental inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappaB through suppression of kappaB kinase activity. | 2003 Aug |
|
Intermediates of Krebs cycle correct the depression of the whole body oxygen consumption and lethal cooling in barbiturate poisoning in rat. | 2004 Oct 1 |
|
The effect of pretreatment with thiopental on reducing pain induced by rocuronium injection. | 2005 Dec 31 |
|
[Comparison of the effectiveness of pentobarbital and thiopental in patients with refractory intracranial hypertension. Preliminary report of 20 patients]. | 2005 Feb |
|
Synergism of isothermal regimen and sodium succinate in experimental therapy of barbiturate coma. | 2006 Jul |
|
Hyperammoniemia in rats with barbiturate coma. | 2007 Mar |
|
Thiopental protects human T lymphocytes from apoptosis in vitro via the expression of heat shock protein 70. | 2008 Apr |
|
The effect of a 3 : 1 volume mixture of propofol 1% and thiopental 2.5% in reducing the pain on injection of propofol in children. | 2010 Jun |
|
Pretreatment with dexmedetomidine or thiopental decreases myoclonus after etomidate: a randomized, double-blind controlled trial. | 2010 Mar |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.medicines.org.uk/emc/medicine/14338
Thiopental Sodium 500 mg Injection is administered intravenously normally as a 2.5% w/v (500 mg in 20 ml) solution. On occasions it may be administered as a 5% w/v solution (500 mg in 10 ml).
The intravenous injection preparation should be used after reconstitution of the sterile powder with Water for Injections, usually to produce a 2.5% w/v solution and this should be discarded after seven hours.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18619475
In cultured spinal cord slices from mice, thiopental reduced action potential activity with an EC50 of 16.6 ± 2.4 μM. Recordings of GABAA and glycine receptor-mediated inhibitory currents indicated that the effect was largely mediated by GABAA receptors and that glycine receptors were not relevant targets. Specifically, 20 μM thiopental prolonged the decay time of spontaneous GABAergic inhibitory postsynaptic currents (sIPSCs) more than twofold. Although this prolongation of decay time increased the inhibitory charge per sIPSC the concomitant strong reduction of sIPSC frequency resulted in less inhibitory current entering the neurons via this route. However, 20 μM thiopental also induced a tonic current of 30 ± 10 pA, mediated by GABAA receptors; 50 μM thiopental nearly abolished sIPSC activity but augmented tonic currents to 69 ± 14 pA.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C67084
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
||
|
NCI_THESAURUS |
C245
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
||
|
CFR |
21 CFR 522.2444
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
||
|
DEA NO. |
2100
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
||
|
CFR |
21 CFR 522.2444A
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
||
|
CFR |
21 CFR 522.2444B
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
102166
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
THIOPENTAL SODIUM
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | Description: A yellowish white powder; odour, characteristic. Solubility: Freely soluble in water and ethanol (~750 g/l) TS; practically insoluble in ether R. Category: General anaesthetic. Storage: Thiopental sodium should be kept in a tightly closed container, protected from light. Additional information: Thiopental sodium is hygroscopic. Even in the absence of light, it is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures. Requirements: Thiopental sodium contains not less than 97.0% and not more than the equivalent of 102.0% of C11H17N2NaO2S, calculated with reference to the dried substance. | ||
|
71-73-8
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
DTXSID1021744
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
200-763-1
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
m10773
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | Merck Index | ||
|
12832575
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
433
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
SUB10981MIG
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
282416
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | RxNorm | ||
|
DBSALT001409
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
100000091816
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
SUB04816MIG
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
CHEMBL441
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
Sodium thiopental
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
9561
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
759557
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
49Y44QZL70
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY | |||
|
C66599
Created by
admin on Fri Dec 15 16:04:43 GMT 2023 , Edited by admin on Fri Dec 15 16:04:43 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD